312615-59-1Relevant articles and documents
TRANSGLUTAMINASE 2 (TG2) INHIBITORS
-
Paragraph 001074, (2020/03/02)
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition.
A convenient synthesis and chemical properties of 3-acylamino-6- polyfluoroalkyl-2H-pyran-2-ones
Gerus, Igor I.,Tolmachova, Nataliya A.,Vdovenko, Sergey I.,Froehlich, Roland,Haufe, Guenter
, p. 1269 - 1278 (2007/10/03)
A number of 3-acylamino-6-polyfluoroalkyl-2H-pyran-2-ones 3 were synthesized from β-alkoxyvinyl polyfluoroalkyl ketones 1 and N-acylglycines 2 in acetic anhydride in high yield. The reactions of trifluoromethyl- containing 2H-pyran-2-one 3b with O-and N-n